510(k) device
Corvus Radiation Therapy Planning System
Best Nomos · System, Planning, Radiation Therapy Treatment (MUJ, Class II) · First FDA decision Feb 23, 2010, newest May 6, 2021Cancer radiation therapy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
0
Naming "Corvus"
MAUDE reports
0
Brand "Corvus", since 2015
PubMed studies
1,007
Mentioning "Corvus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Corvus Radiation Therapy Planning System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K211034 · Decided May 6, 2021 · 29 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40168Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40179CGS Administrators, LLCUpdated Apr 17, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40193WPS Insurance CorporationUpdated Mar 12, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40189Palmetto GBAUpdated Mar 11, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40176Noridian Healthcare Solutions, LLCUpdated Mar 10, 2026
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Hyperbaric Oxygen Therapy for Chronic Radiation Induced Proctitis and EnteritisNational analysisReview closedCAG-00060R2Updated Nov 18, 2026
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Corvus", any status and sponsor, newest update first.
No registered device study names "Corvus".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Corvus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MUJ
305 reports: 245 malfunction, 49 injury, 5 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Corvus"[tiab]. The summary above synthesizes these.
- Vocal efficiency in crows.
Wascher CAF, Youngblood M · Anim Cogn · 2025
- Hooded crows (Corvus cornix) manufacture objects relative to a mental template.
Smirnova AA, Bulgakova LR, Cheplakova MA, et al. · Anim Cogn · 2024Research Support, Non-U.S. Gov't
- Transcriptome analysis of Corvus splendens reveals a repertoire of antimicrobial peptides.
Kannoth S, Ali N, Prasanth GK, et al. · Sci Rep · 2023Research Support, Non-U.S. Gov't
- Corvids optimize working memory by categorizing continuous stimuli.
Apostel A, Panichello M, Buschman TJ, et al. · Commun Biol · 2023Research Support, Non-U.S. Gov't
- Stick dexterity in carrion crows.
Sugasawa S · Learn Behav · 2026
- Competition and generalization impede cultural formation in wild jackdaws.
Arbon JJ, Hahn LG, McIvor GE, et al. · Proc Biol Sci · 2023Research Support, Non-U.S. Gov't
- Numerical Representation for Action in Crows Obeys the Weber-Fechner Law.
Kirschhock ME, Nieder A · Psychol Sci · 2023Research Support, Non-U.S. Gov't
- Synanthropic birds and parasites.
Dipineto L, Borrelli L, Pepe P, et al. · Avian Dis · 2013
- Satellite DNA evolution in Corvoidea inferred from short and long reads.
Peona V, Kutschera VE, Blom MPK, et al. · Mol Ecol · 2023Research Support, Non-U.S. Gov't
- Genomic evidence of speciation reversal in ravens.
Kearns AM, Restani M, Szabo I, et al. · Nat Commun · 2018Research Support, Non-U.S. Gov't
- Wild jackdaws can selectively adjust their social associations while preserving valuable long-term relationships.
Kings M, Arbon JJ, McIvor GE, et al. · Nat Commun · 2023Research Support, Non-U.S. Gov't
- Carrion crows (Corvus corone) of southwest Germany: important hosts for haemosporidian parasites.
Schmid S, Fachet K, Dinkel A, et al. · Malar J · 2017Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MUJ.
- Eclipse Treatment Planning System (18.1)Varian Medical Systems · 510(k) 2024
- syngo.via RT Image SuiteSiemens Medical Solutions USA, Inc. · 510(k) 2024
- RayStation (2024A SP3)RaySearch Laboratories AB (PUBL) · 510(k) 2025
- RT Elements (4.5)Brainlab AG · 510(k) 2025
- Monaco RTP System (6.3)Elekta Solutions AB · 510(k) 2026
- Cyberknife Robotic Radiosurgery SystemAccuray, Inc. · 510(k) 2006
- ClearCalc Model RADCA V2.6Radformation, Inc. · 510(k) 2025
- OncospaceOncospace, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.